Evidence map›Paper›PMID 38564699›Full record

ArticlemBio2024

Genomic context as well as sequence of both

Kavindra V Singh, Jessica Galloway-Peña, Maria Camila Montealegre, Xingxing Dong, Barbara E Murray

Open access · goldAbstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Pathogens (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kavindra V SinghDivision of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas, USA.ORCID 0000-0003-3005-3982
Jessica Galloway-PeñaDivision of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas, USA.ORCID 0000-0003-1081-254X
Maria Camila MontealegreDivision of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas, USA.ORCID 0000-0001-9639-9690
Xingxing DongDivision of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas, USA.
Barbara E MurrayDivision of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas, USA.ORCID 0000-0003-4461-6870
The University of Texas Health Science Center at Houston · US

Funding

Molecular Basis of Infectious Diseases Training GrantT32AI055449 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LORENZ, MICHAEL C · 2005 to 2025
$2.6M
Developing a better understanding of expression and function of PBP5-R of Enterococcus faecium for future development of therapeutic modalities for VRE infectionsR21AI133289 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MURRAY, BARBARA E · 2018 to 2019
$439k
NIAID NIH HHS R21 AI133289NIAID NIH HHS T32 AI055449
6 · The paper itself

Abstract

Penicillin-binding protein 5 (PBP5) of IMPORTANCE: The findings of this study shed light on ampicillin resistance in

Indexed as

Anti-Bacterial Agentsbeta-Lactam ResistanceEnterococcus faeciumPenicillin-Binding ProteinsAmpicillinBacterial ProteinsGenome, BacterialMicrobial Sensitivity TestsAmpicillinAnti-Bacterial AgentsBacterial ProteinsPbp5 protein, Enterococcus faeciumPenicillin-Binding Proteinsampicillin resistanceE. faeciumPBP5Psr

Identifiers

PMID38564699
PMCPMC11077988
OpenAlexW4393405023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.